Chemotherapy of MMR-deficient colorectal cancer

@article{Devaud2013ChemotherapyOM,
  title={Chemotherapy of MMR-deficient colorectal cancer},
  author={Nicol{\'a}s Devaud and Steven Gallinger},
  journal={Familial Cancer},
  year={2013},
  volume={12},
  pages={301-306}
}
Colorectal cancer (CRC) continues to rank as the third most common cancer in Western society and the second leading cause of cancer death in North America. There are at least three distinct, and relatively discreet, molecular pathways associated with this disease: chromosomal instability (CIN), microsatellite instability (MSI) and the cytosine polyguanine island methylator phenotype. Defects in the DNA mismatch repair system (MMR) account for the MSI phenotype and genotype of about 15 % of CRC… CONTINUE READING
17 Citations
52 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 52 references

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy

  • ST Kim
  • Cancer Chemother Pharmacol
  • 2010
Highly Influential
6 Excerpts

The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer

  • ST Kim
  • Med Oncol
  • 2010
Highly Influential
6 Excerpts

Clinical relevance of microsatellite instability in colorectal cancer

  • A de la Chapelle, H Hampel
  • J Clin Oncol
  • 2010
2 Excerpts

Similar Papers

Loading similar papers…